Retatrutide

Retatrutide is a synthetic investigational peptide studied for its triple receptor agonist activity at glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. In controlled laboratory research settings, GLP-3 (GLP-1/GIP/GCG) has been evaluated for its receptor-binding dynamics and its influence on metabolic signaling pathways. Its multi-receptor profile makes it a compound of significant interest in advanced metabolic and endocrine research models.

Preclinical investigations have explored Retatrutide for its interaction with pathways associated with glucose regulation, nutrient metabolism, and systemic energy balance. Ongoing scientific research continues to examine its downstream cellular signaling mechanisms and its pharmacodynamic behavior in experimental metabolic frameworks. Its tri-agonist structure differentiates it from single and dual receptor peptides studied in similar research domains.

This research peptide is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm identity, purity, and structural integrity. Retatrutide is intended strictly for laboratory research and analytical purposes only and is not for human consumption.